Rabeprazole FDA Link

A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Also Known As:

Aciphex; 1H-Benzimidazole, 2- (((4- (3- methoxypropoxy)- 3- methyl- 2- pyridinyl)methyl)sulfinyl)- , Sodium Salt; 2- ((4- (3- methoxypropoxy)- 3- methylpyridin- 2- yl)methylsulfinyl)- 1H- benzimidazole; Dexrabeprazole; E 3810; E3810; LY-307640; LY307640; Pariet; Rabeprazole Sodium; LY 307640; Sodium, Rabeprazole

Pharmalogical Action Categories:

Anti-Ulcer Agents
Proton Pump Inhibitors

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfoxides: 23
    - 2-Pyridinylmethylsulfinylbenzimidazoles
      - Rabeprazole: 517
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2-Pyridinylmethylsulfinylbenzimidazoles
      - Rabeprazole: 517
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 2-Pyridinylmethylsulfinylbenzimidazoles
        Rabeprazole: 517

J Breiter Selected Research

J Breiter Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure